Best Practices For Gaining Stakeholder Buy-In For Data Linkage In Clinical Trials
Data linkage lets sponsors link CTD with RWD at the patient level across current and completed trials—regardless of consent method—in a privacy-certified, CRO-agnostic manner while supporting multiple de-identification token schemas. It also lets sponsors track post-trial outcomes, enhance safety surveillance, and reduce burdensome follow-up visits. However, while the value of data linkage may be apparent to some, gaining patient, investigator, and internal organizational buy-in presents a barrier to evangelizing and championing data linkage.
To find out more about Medidata Solutions, visit their Clinical Leader page.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.